Jonathan Meiss Siner MD

Assistant Professor of Medicine (Pulmonary); Medical Director - Medical Intensive Care Unit, Yale-New Haven Hospital

Clinical Interests

Intensive Care Medicine (Critical Care); Acute Respiratory Distress Syndrome (ARDS); Sepsis; Interstitial Lung Diseases (ILD); Idiopathic Pulmonary Fibrosis (IPF)


Board Certifications

2004
Pulmonary Disease, Board Certified
2005
Critical Care Medicine, Internal Medicine, Board Certified
2001
Internal Medicine, Board Certified

Patient Care Locations

 
jonathan_sinerfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Alpha 1 Antitrypsin Deficiency and AATD (GRADS)(A) - Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis
Idiopathic Pulmonary Fibrosis (RAINIER) A Phase 2, Randomized, Double Blind, Placebo Controlled, Multi-Center Study to Assess the Efficacy and safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (GS-US-322-027)
Sarcoidosis (GRADS)(B) - Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidsosis
Idiopathic Pulmonary Fibrosis (GB28547) A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis (BMS-IM136003) Clinical protocol IM136003 and efficacy of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis, a multicenter, randomized, double-blind, placebo-controlled phase 2 study of the safety and efficacy of BMS-986020 in subjects with IPF

More Clinical Trials...

Edit Profile